Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Prospective Trial of Memantine in the Treatment of Moderate to Severe Binge Eating Disorder Associated With Obesity

NCT00330655 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT00330655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Prospective Trial of Memantine in the Treatment of Moderate to Severe Binge Eating Disorder Associated With Obesity
Lead sponsor
Mclean Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
July 31, 2007
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder